Indegene Limited has released the Monitoring Agency Report for the quarter ended March 31, 2026, concerning the utilization of its initial public offering (IPO) proceeds. The report confirms that there have been no deviations in the objectives of the fund utilization. As of the end of the quarter, a significant portion of the ₹760 crore issue size has been deployed toward capital expenditure, technology upgrades, and debt repayment, with ongoing monitoring of the remaining funds.
IPO Proceeds Utilization Update
The monitoring agency, Care Edge Ratings, has confirmed that the utilization of funds from Indegene Limited’s ₹760 crore IPO is consistent with the objectives outlined in the company’s offer document. For the quarter ended March 31, 2026, the company successfully completed the utilization toward issue-related expenses, with any surplus funds being reallocated to support infrastructure and civil works as approved by the board.
Strategic Deployment of Funds
Key highlights regarding the allocation of funds include:
- Debt Repayment: The full amount designated for the repayment and prepayment of indebtedness of ILSL Holdings, Inc. has been utilized, totaling ₹395 crore.
- Capital Expenditure: A total of ₹57.77 crore has been deployed toward capital expenditure, which includes investments in company infrastructure, computing equipment, and peripherals.
- Technology Investment: Approximately ₹25.26 crore was utilized during the quarter for technology, cybersecurity, and cloud infrastructure initiatives, including software licensing and subscriptions.
Future Outlook and Compliance
The company maintains a strong focus on project execution. While minor delays were noted in the deployment of funds for specific capital expenditure milestones, these have been managed through board-approved adjustments and strategic reallocations. As of March 31, 2026, the company holds approximately ₹17.26 crore in unutilized proceeds, which are being held in secure instruments, including ICICI Bank fixed deposits, to earn interest while awaiting further deployment toward approved corporate objectives.
Source: BSE
